Amends the Federal Food, Drug, and Cosmetic Act to extend the inspection authority of the Food and Drug Administration (FDA) over records ( currently limited to manufacturers and distributors of prescription drugs) to manufacturers and distributors of drugs containing caffeine and ephedrine. Permits the Secretary of Health and Human Services to add additional substances to this list, through notice and comment rulemaking, if they become substances of abuse.
Prohibits the manufacture and distribution of drugs which a reasonable person would believe to be a controlled substance.
Repeals the prohibition on obtaining injunctions against the manufacturers and distributors of counterfeit drugs and the making, selling or concealing of the equipment used to make counterfeit drugs.
Extends the FDA's seizure authority to prohibited look-alike drugs.
Introduced in Senate
Read twice and referred to the Committee on Labor and Human Resources.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line